European Journal of Obstetrics & Gynecology and Reproductive Biology
Volume 95, Issue 1 , Pages 127-131, March 2001

Perception of teratogenic risk of common medicines

Department of Pharmacology, School of Medicine, University of La Laguna, La Laguna, Tenerife, Canary Islands, Spain

Accepted 21 April 2000.

Abstract 

Objective: To assess the perception of the teratogenic risk of common medication by professionals and lay people. Study Design: A visual-analogue scale was used to measure the perceived percentage of mothers who will deliver a child with a malformation, including those exposed to a list of drugs. Fifteen general practitioners, 10 gynaecologists, 106 pre-clinical students, 150 students in their clinical training, 81 pregnant women and 63 non-pregnant women were interviewed. Results: The perception of the teratogenic risk related to medication used in pregnancy was higher than the recognised risk in all groups, and for all drugs. The risk associated with safe medications was perceived to be higher by non-pregnant women as compared with the pregnant women. Pregnant women perceived the medication associated risk to be higher than physicians did for all drugs included in the questionnaire. Conclusions: The high and unrealistic perception of teratogenic risk amongst women and health professionals may lead to abortions of otherwise wanted and healthy children.

Keywords:  Foetal development, Drug effects, Pregnancy complications, Drug therapy, Abnormalities, Drug-induced, Etiology, Perceptions, Risk factors, Attitude to health

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0301-2115(00)00375-4

European Journal of Obstetrics & Gynecology and Reproductive Biology
Volume 95, Issue 1 , Pages 127-131, March 2001